Abhinav Jain

Insider Reports History

Location
Englewood, CO
Signature
/s/ Amy Culbert, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Abhinav Jain:

Company Role Class Num Shares Value Price $ Report Date Ownership
Xtant Medical Holdings, Inc. Director Common Stock 158,228 $121,835 $0.7700 15 Nov 2025 Direct
AYTU BIOPHARMA, INC Director Common Stock 19,500 $45,825 $2.35 03 Oct 2025 Direct
TALPHERA, INC. Director Common Stock 7,312 $6,520 $0.8918 23 Oct 2025 Direct
TALPHERA, INC. Director Stock Option (Right to Buy) 25,600 23 Oct 2025 Direct

Insider Reports Filed by Abhinav Jain

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XTNT Xtant Medical Holdings, Inc. 15 Nov 2025 1 $0 4 Director 18 Nov 2025, 17:11
TLPH TALPHERA, INC. 23 Oct 2025 2 $0 4 Director 24 Oct 2025, 16:41
AYTU AYTU BIOPHARMA, INC 03 Oct 2025 1 $0 4 Director 07 Oct 2025, 16:09
XTNT Xtant Medical Holdings, Inc. 01 Aug 2025 0 $0 3 Director 08 Aug 2025, 16:11
AYTU AYTU BIOPHARMA, INC 06 Nov 2024 1 $0 4 Director 08 Nov 2024, 20:27
TLPH TALPHERA, INC. 24 Jun 2024 2 $0 4 Director 24 Jun 2024, 19:10
TLPH TALPHERA, INC. 22 Jan 2024 2 $0 4 Director 23 Jan 2024, 17:22
TLPH TALPHERA, INC. 22 Jan 2024 0 $0 3 Director 23 Jan 2024, 17:21
AYTU AYTU BIOPHARMA, INC 16 Aug 2023 1 $0 4 Director 18 Aug 2023, 18:27
AYTU AYTU BIOPHARMA, INC 11 Aug 2023 1 $0 4 Director 15 Aug 2023, 19:49
AYTU AYTU BIOPHARMA, INC 13 Jun 2023 0 $0 3 Director 15 Jun 2023, 10:42
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .